1. Home
  2. HDSN vs RCKT Comparison

HDSN vs RCKT Comparison

Compare HDSN & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hudson Technologies Inc.

HDSN

Hudson Technologies Inc.

HOLD

Current Price

$7.31

Market Cap

409.2M

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.32

Market Cap

340.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HDSN
RCKT
Founded
1991
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
409.2M
340.9M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
HDSN
RCKT
Price
$7.31
$3.32
Analyst Decision
Strong Buy
Buy
Analyst Count
2
14
Target Price
$9.50
$29.12
AVG Volume (30 Days)
524.0K
2.0M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.50
N/A
Revenue
$236,847,000.00
N/A
Revenue This Year
$2.65
N/A
Revenue Next Year
$3.69
N/A
P/E Ratio
$14.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.11
$2.19
52 Week High
$10.52
$15.00

Technical Indicators

Market Signals
Indicator
HDSN
RCKT
Relative Strength Index (RSI) 46.12 51.21
Support Level $6.53 $3.08
Resistance Level $7.74 $3.45
Average True Range (ATR) 0.27 0.18
MACD 0.17 0.05
Stochastic Oscillator 63.64 75.00

Price Performance

Historical Comparison
HDSN
RCKT

About HDSN Hudson Technologies Inc.

Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: